Outcome of renal allograft recipients at Saint Paul’s hospital millennium medical college, national kidney transplant center Addis Ababa, Ethiopia
Background: Kidney transplant is the current modality of choice as a renal replacement therapy due to superior patient survival and quality of life than both peritoneal and hemodialysis. The service is limited outside ofdeveloped countries due to the requirement for structured organization, extended expertise, and qualified supportive laboratory, as well as extensive health system service support in general.
Objective: The aim of the study is to describe renal allograftrecipient outcomes during the first two years following establishment of the national kidney transplant center in AddisAbaba, Ethiopia.
Methods: A retrospective review of the case records of all recipients of renal allografts at Saint Paul’sHospital MillenniumMedical College between September 2015 and August 2017 wasdone.
Results:52 live donor kidney transplants were performedover two years.The cause of native kidney diseases was unknown in majority(32.6%),while chronic glomerulonephritis accounted for 30.8%. One fourth of recipients were transfused at least once before transplant. There was no biopsy proven rejection episode. There was one early graft loss from unknown cause. Atleast one organ system was affected with drug side effects in nearly in all(96%), leucopenia occurring in one fourth(22%) was very serious.Death censored graft survival at one year is 97.5% while mean GFR at one week, three month, six month and one year was 73.1, 93.6, 95.6, and96ml/min, respectively.After successful kidney transplant pre-transplant hypertension subsided in 46.5% of patients.
Conclusion: Graft survival and graft function at one year, were excellent, and comparable to excellent centers worldwide.
Key Words – Ethiopia, kidney, transplant, outcome
2. R J Johnson, J Feehally, Comprehensive clinical nephrology, elshevir saunders phyladelphia 2015
3. WHO organ transplant outcome 2018http://www.who.int/transplantation/gkt/statistics/kidney_outcomes/en/
4. Douglas Scott Keith, Gayle Vranic, and Angie Nishio-Lucar, Graft Function and Intermediate-Term Outcomes of Kidney Transplants Improved in the Last Decade: Analysis of the United States Kidney Transplant Database
5. Fu Liang Ng1,2, David W. Holt3 Black renal transplant recipients have poorer long-term graft survival than CYP3A5 expressers from other ethnic groups
6. Jacob A. Akoh Renal Transplantation in Developing Countries Saudi J Kidney Dis Transpl 2011;22(4):637-650
7. John GT, Shankar V, Abraham AM, Mukundan U, Thomas PP, Jacob CK. Risk factors for post-transplant tuberculosis. Kidney Int 2001; 60:1148-53.
8. Karima Boubaker,1 Tahar Gargah Mycobacterium tuberculosis Infection followingKidney Transplantation Hindawi Publishing Corporation BioMed Research International Volume 2013, Article ID 347103
9. Muller E Transplantation in Africa - an overview. Clin Nephrol. 2016 Supplement 1;86 (2016)(13):90-95
10. Colleen L. Jay,1 Patrick G,,2 Ryan A. Helmick Reassessing Preemptive Kidney Transplantation in the United States: Are we making progress? University of Texas Health Science Center, May 2016
11. Umezurike Hughes Okafor , Kidney transplant in Nigeria: a single centre experience pan african medical journal 25 10 2016
12. Santos CA, Brennan DC, Fraser VJ, Delayed-onset cytomegalovirus disease coded during hospital readmission after kidney transplantation. Olsen Transplantation. PubMed 2014;98(2):187
13. João Egidio Romão Junio Tuberculosis in renal transplant recipients: Challenges in developing countries J. Bras. Nefrol. vol.36 no.4 São Paulo Oct./Dec. 2014
14. S C Alagbe, A Voster, R Ramesar, C R Swanepoel New-onset diabetes after transplant: Incidence, risk factors and outcome SAMJ 2017-08-25
15. AU Paoletti E, Gherzi M, Amidone Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring. G SO Transplantation. 2009;87(12):1864.
16. Brum S, Nolasco F, Sousa Leukopenia in kidney transplant patients with the association of valganciclovir and mycophenolate mofetil. Transplant Proc. 2008 Apr;40(3):752-4